Bio X Cell has expanded its bispecific antibody offerings, including a growing portfolio of ready-to-ship anti-mouse bispecific antibodies and custom bispecific antibody production services designed to support preclinical research.
These ready-to-ship anti-mouse bispecific antibodies offer preclinical researchers the first-to-market RUO quality, off-the-shelf anti-mouse bispecific antibodies to enable critical preclinical and translational research.
Bispecific antibodies are increasingly used earlier in preclinical studies to interrogate complex pathway interactions and immune mechanisms. As dual-target strategies advance upstream, research teams require reliable access to functional bispecific tools that perform consistently in living systems and can adapt as programs evolve.
Bio X Cell’s expanded bispecific portfolio provides immediate access to research-use-only, in vivo-ready bispecific antibodies designed for evaluation in established preclinical models. The portfolio includes both anti-mouse and anti-human bispecific formats, supporting dual-target studies in standard preclinical systems as well as translational research applications. These reagents enable early mechanistic studies within well-characterized biological environments, supporting clearer interpretation of dual-target activity.
All bispecific antibodies are produced using ultra-pure, low-endotoxin, carrier-free formulations engineered to support reproducibility in vivo studies.